Login

Interpump Unveils Innovative Solutions at IAA | Fabio Marasi - CEO of Interpump Group S.p.A. 00:10:00

Share On Facebook Share On Twitter

Fabio Marasi is the CEO of Interpump Group.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
AES CEO Andrés Gluski discusses his company's strategy for using renewable energy methods to power data centers in an interview with Alix Steel.
00:00:00
4D Pharma raises $40 million - Duncan Peyton, CEO, 4D Pharma
00:10:00
Cutting Through the Noise: Investing Wisely and Understanding the Market | Phil Ball, President , Bollin Wealth Management LLC.
00:10:00
The Company through its subsidiaries provides investment management and advisory services.|Tim Collins,CEO,Ripplewood Holding
00:00:00
Zami Aberman, CEO, Pluristem Therapeutics Inc
00:10:00
The Nuances of Commercial Real Estate: Insights from an Industry Leader | Michelle M. MacKay, CEO,Cushman & Wakefield PLC.
00:10:00
Theta Gold Mines: Progressing Towards Production at the One-to-One Mining Investment Conference
00:10:00
long-time early-stage investor currently investing out of their 12th Fund which worth$800M.|Stephen Bloch,General Partner,Canaan Partners
00:10:00
Understanding 409A Valuations: Key Insights for Employee Stock Compensation | Mark Dempster, Co-Founder, Founders Circle Capital.
00:00:00
Carlos Ponce, MD, PhD Assistant Professor of Neurobiology, HMS
00:00:00
Dr. Stephen Mcleod, CEO of the American Academy of Ophthalmology
00:10:00
Investment in digital bank Revolut, valued at $25.7 billion|Martin Mignot,investor,Index Ventures

© 2017 - Neuhu+